Biomarker sources for Parkinson's disease: Time to shed tears?
Authors:
- M. BörgerMBM. Börger
- S. FunkeSFS. Funke
- M. BährMBM. Bähr
- F. GrusFGF. Grus
- P. LingorPLP. Lingor
- 1 August 2015
- journal article
- Published by Elsevier in Basal Ganglia
- Vol. 5 (2-3) , 63-69
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic reviewActa Neurologica Scandinavica, 2014
- Diagnosis and Differential Diagnosis of Parkinson’s Disease2011
- Epidemiology and etiology of Parkinson’s disease: a review of the evidenceEuropean Journal of Epidemiology, 2011
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteriaThe Lancet Neurology, 2009
- Biomarkers of Alzheimer's diseaseNeurobiology of Disease, 2009
- Epidemiology of Parkinson's diseaseThe Lancet Neurology, 2006
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder serviceBrain, 2002
- Considerations in the Evaluation of Surrogate Endpoints in Clinical TrialsControlled Clinical Trials, 2001
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Diagnostic Criteria for Parkinson DiseaseArchives of Neurology, 1999